The GLP-1 boom is pushing companies across consumer industries to rethink what people eat, drink, and buy. Weight-loss drugs are creating new demand beyond the pharmaceutical sector. Companies now see opportunities in nutrition, food, beverages...
AI innovation is accelerating across India’s drug development, approvals, medical devices and specialized healthcare ecosystem
Lung cancer trial development at AstraZeneca has hit a setback. The company discontinued its Phase III eVOLVE-Lung02 study of volrustomig with chemotherapy in metastatic non-small cell lung cancer
Lupin has received a key FDA approval that strengthens its position in sleep disorder drugs. The approval covers its generic Pitolisant Tablets for the US market. The latest regulatory clearance allows Lupin to market Pitolisant Tablets in 4.45 mg...
Pharmaceutical growth in India is entering a phase where CDMOs can play a larger role in shaping manufacturing, innovation, and global market access
Telangana has brought its Food Safety Department and Drugs Control Administration under one administrative structure called the Telangana Standards Authority for Food and Essential Drugs
FDA observation outcomes at Aurobindo Pharma's Raleigh facility have moved into a new phase after the US regulator classified the site as Voluntary Action Indicated
Sun Pharma has secured major relief in its long-running Antitrust litigation in the U.S. The company said a U.S. appeals court upheld a lower court ruling in its favor. The case relates to generic Lipitor and a patent settlement involving Ranbaxy...
The latest pharma updates spotlight key developments in drug safety, regulatory compliance, clinical practice, disease preparedness and global ambitions
Chandipura Virus cases have surged in Gujarat, with the death toll reaching 27. The state has reported 41 confirmed infections so far. The outbreak has raised concern due to the virus's rapid progression. Chandipura virus cases have mainly been...